PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

Trial ID or NCT#

NCT04889872

Status

recruiting iconRECRUITING

Purpose

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

Official Title

The PROGRESS Trial: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Christiane Haeffele
Christiane Haeffele
Adult congenital heart disease cardiologist, Cardiologist
Clinical Associate Professor, Medicine - Cardiovascular Medicine Clinical Assistant Professor, Pediatrics - Cardiology
Rahul P Sharma, MBBS, FRACP
Rahul P Sharma, MBBS, FRACP
Cardiologist, Interventional cardiologist
Clinical Professor, Medicine - Cardiovascular Medicine
Alan Ching Yuen Yeung
Alan Ching Yuen Yeung
Interventional cardiologist, Cardiologist
Li Ka Shing Professor in Cardiology

View on ClinicalTrials.gov